What types of genetic testing can be performed on tissue removed during a dilation and curettage (D&C) procedure for a patient who has experienced a missed miscarriage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Genetic Testing Options for Missed Miscarriage Tissue from D&C

The primary genetic test to perform on tissue from a D&C for missed miscarriage is chromosomal microarray analysis (CMA), which can identify chromosomal abnormalities in approximately 50% of first trimester losses and provides results even when tissue culture fails. 1, 2

Primary Testing Modality

Chromosomal Microarray Analysis (CMA)

  • CMA using single nucleotide polymorphism (SNP) microarray or array comparative genomic hybridization (aCGH) is the preferred first-line test because it detects both aneuploidy and copy number variants without requiring cell culture 1, 2
  • This 24-chromosome microarray analysis identifies a definite cause in approximately 67% of recurrent pregnancy loss cases 3
  • CMA has higher success rates than traditional karyotyping because it can analyze DNA directly from tissue without requiring viable cells for culture 1

Alternative and Complementary Testing Options

Traditional Cytogenetic Karyotyping

  • Conventional karyotyping requires viable cells and tissue culture, which has higher failure rates (10-40%) compared to CMA 1
  • Should be offered on pregnancy tissue of the third and subsequent miscarriage(s) and in any second trimester miscarriage 4
  • Fresh tissue or cultured cells such as fibroblasts are more successful in yielding results than formalin-fixed tissue 5

Exome or Genome Sequencing

  • Exome or genome sequencing may be appropriate depending on clinical indication, particularly when CMA is normal but there is suspicion of a genetic cause 5
  • Gene panels followed by reflex exome/genome sequencing can be considered in specific circumstances 5

Copy Number Variant (CNV) Analysis

  • CNV analysis should be offered along with single-nucleotide variant (SNV) analysis, as many genes can have copy number variants that may be missed with SNV analysis alone 5

Mitochondrial Genome Analysis

  • Mitochondrial genome analysis should be considered in addition to nuclear genome analysis in appropriate cases 5

Specimen Collection and Handling Considerations

Optimal Sample Types

  • Fresh tissue collected in sterile containers is ideal for genetic testing 5
  • Purple top EDTA tubes for DNA preservation should be used when collecting blood or tissue samples 5
  • Formalin-fixed paraffin-embedded tissue can be used but has lower success rates due to DNA degradation 5

Samples to Avoid

  • Hair, vitreous fluid, synovial fluid, and urine are not good candidates due to low DNA yield and contamination risk 5

Clinical Context and Timing

When to Test

  • Cytogenetic analysis should be offered on the third and subsequent miscarriage(s) 4
  • Testing after the second miscarriage combined with standard recurrent pregnancy loss workup identifies a cause in over 90% of cases 2, 3
  • Any second trimester miscarriage warrants genetic testing 4

Cost-Effectiveness

  • Initial 24-chromosome microarray analysis on miscarriage tissue results in 50% cost savings compared to performing full recurrent pregnancy loss workup first 3
  • This approach reduces unnecessary testing in patients whose losses are explained by chromosomal abnormalities 3

Important Caveats

Maternal Cell Contamination

  • Maternal cell contamination can occur and lead to false-negative results, requiring careful laboratory interpretation 3
  • Sample collection technique and timing affect contamination risk 5

Test Limitations

  • A negative genetic test does not exclude a genetic cause for pregnancy loss 5
  • Approximately 50% of first trimester miscarriages have chromosomal abnormalities, meaning half will have normal genetic testing 1, 3

Follow-up Testing

  • If an unbalanced structural chromosomal abnormality is found in pregnancy tissue, parental peripheral blood karyotyping should be offered 4
  • Parental karyotyping should also be offered when pregnancy tissue testing is unsuccessful or unavailable 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.